These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30815157)

  • 21. Improved motor outcome prediction in Parkinson's disease applying deep learning to DaTscan SPECT images.
    Adams MP; Rahmim A; Tang J
    Comput Biol Med; 2021 May; 132():104312. PubMed ID: 33892414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. fNIRS-based graph frequency analysis to identify mild cognitive impairment in Parkinson's disease.
    Shu Z; Wang J; Cheng Y; Lu J; Lin J; Wang Y; Zhang X; Yu Y; Zhu Z; Han J; Wu J; Yu N
    J Neurosci Methods; 2024 Feb; 402():110031. PubMed ID: 38040127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The exploration of Parkinson's disease: a multi-modal data analysis of resting functional magnetic resonance imaging and gene data.
    Bi XA; Wu H; Xie Y; Zhang L; Luo X; Fu Y;
    Brain Imaging Behav; 2021 Aug; 15(4):1986-1996. PubMed ID: 32990896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Anatomical and Diffusion MRI for detecting Parkinson's Disease using Deep Convolutional Neural Network.
    Chattopadhyay T; Singh A; Laltoo E; Boyle CP; Owens-Walton C; Chen YL; Cook P; McMillan C; Tsai CC; Wang JJ; Wu YR; van der Werf Y; Thompson PM
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-6. PubMed ID: 38083460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying and distinguishing of essential tremor and Parkinson's disease with grouped stability analysis based on searchlight-based MVPA.
    Cheng F; Duan Y; Jiang H; Zeng Y; Chen X; Qin L; Zhao L; Yi F; Tang Y; Liu C
    Biomed Eng Online; 2022 Nov; 21(1):81. PubMed ID: 36443843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An easy-to-use deep-learning model for highly accurate diagnosis of Parkinson's disease using SPECT images.
    Mohammed F; He X; Lin Y
    Comput Med Imaging Graph; 2021 Jan; 87():101810. PubMed ID: 33279760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson's disease.
    Abbasi N; Mohajer B; Abbasi S; Hasanabadi P; Abdolalizadeh A; Rajimehr R
    Mov Disord; 2018 Mar; 33(3):431-439. PubMed ID: 29436735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personalized Prediction of Parkinson's Disease Progression Based on Deep Gaussian Processes.
    Pan C; Tian Y; Zhou T; Li J
    Stud Health Technol Inform; 2024 Jan; 310():765-769. PubMed ID: 38269912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complex networks reveal early MRI markers of Parkinson's disease.
    Amoroso N; La Rocca M; Monaco A; Bellotti R; Tangaro S
    Med Image Anal; 2018 Aug; 48():12-24. PubMed ID: 29807313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graph theory and network topological metrics may be the potential biomarker in Parkinson's disease.
    Huang LC; Wu PA; Lin SZ; Pang CY; Chen SY
    J Clin Neurosci; 2019 Oct; 68():235-242. PubMed ID: 31420273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Explainable classification of Parkinson's disease using deep learning trained on a large multi-center database of T1-weighted MRI datasets.
    Camacho M; Wilms M; Mouches P; Almgren H; Souza R; Camicioli R; Ismail Z; Monchi O; Forkert ND
    Neuroimage Clin; 2023; 38():103405. PubMed ID: 37079936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging.
    Yang J; Burciu RG; Vaillancourt DE
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):83. PubMed ID: 30280267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voxel-based diktiometry: Combining convolutional neural networks with voxel-based analysis and its application in diffusion tensor imaging for Parkinson's disease.
    Estudillo-Romero A; Haegelen C; Jannin P; Baxter JSH
    Hum Brain Mapp; 2022 Nov; 43(16):4835-4851. PubMed ID: 35841274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis.
    Conrado DJ; Nicholas T; Tsai K; Macha S; Sinha V; Stone J; Corrigan B; Bani M; Muglia P; Watson IA; Kern VD; Sheveleva E; Marek K; Stephenson DT; Romero K;
    Clin Transl Sci; 2018 Jan; 11(1):63-70. PubMed ID: 28749580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroimaging of Parkinson's disease by quantitative susceptibility mapping.
    Guan X; Lancione M; Ayton S; Dusek P; Langkammer C; Zhang M
    Neuroimage; 2024 Apr; 289():120547. PubMed ID: 38373677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extrastriatal
    Nicastro N; Garibotto V; Burkhard PR
    BMC Neurol; 2020 May; 20(1):192. PubMed ID: 32416724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.
    Kang JH; Mollenhauer B; Coffey CS; Toledo JB; Weintraub D; Galasko DR; Irwin DJ; Van Deerlin V; Chen-Plotkin AS; Caspell-Garcia C; Waligórska T; Taylor P; Shah N; Pan S; Zero P; Frasier M; Marek K; Kieburtz K; Jennings D; Tanner CM; Simuni T; Singleton A; Toga AW; Chowdhury S; Trojanowski JQ; Shaw LM;
    Acta Neuropathol; 2016 Jun; 131(6):935-49. PubMed ID: 27021906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automatic classification of dopamine transporter SPECT: deep convolutional neural networks can be trained to be robust with respect to variable image characteristics.
    Wenzel M; Milletari F; Krüger J; Lange C; Schenk M; Apostolova I; Klutmann S; Ehrenburg M; Buchert R
    Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2800-2811. PubMed ID: 31473800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporating spatial constraint in co-activation pattern analysis to explore the dynamics of resting-state networks: An application to Parkinson's disease.
    Zhuang X; Walsh RR; Sreenivasan K; Yang Z; Mishra V; Cordes D
    Neuroimage; 2018 May; 172():64-84. PubMed ID: 29355770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's disease.
    Sreenivasan K; Mishra V; Bird C; Zhuang X; Yang Z; Cordes D; Walsh RR
    Parkinsonism Relat Disord; 2019 May; 62():3-9. PubMed ID: 30772280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.